Document And Entity Information - USD ($)
|
12 Months Ended |
|
|
Dec. 31, 2021 |
Mar. 07, 2022 |
Jun. 30, 2021 |
| Document Information [Line Items] |
|
|
|
| Entity Central Index Key |
0001427925
|
|
|
| Entity Registrant Name |
ACELRX PHARMACEUTICALS INC
|
|
|
| Amendment Flag |
false
|
|
|
| Current Fiscal Year End Date |
--12-31
|
|
|
| Document Fiscal Period Focus |
FY
|
|
|
| Document Fiscal Year Focus |
2021
|
|
|
| Document Type |
10-K
|
|
|
| Document Annual Report |
true
|
|
|
| Document Period End Date |
Dec. 31, 2021
|
|
|
| Document Transition Report |
false
|
|
|
| Entity File Number |
001-35068
|
|
|
| Entity Incorporation, State or Country Code |
DE
|
|
|
| Entity Tax Identification Number |
41-2193603
|
|
|
| Entity Address, Address Line One |
25821 Industrial Boulevard, Suite 400
|
|
|
| Entity Address, City or Town |
Hayward
|
|
|
| Entity Address, State or Province |
CA
|
|
|
| Entity Address, Postal Zip Code |
94545
|
|
|
| City Area Code |
650
|
|
|
| Local Phone Number |
216-3500
|
|
|
| Title of 12(b) Security |
Common Stock, $0.001 par value
|
|
|
| Trading Symbol |
ACRX
|
|
|
| Security Exchange Name |
NASDAQ
|
|
|
| Entity Well-known Seasoned Issuer |
No
|
|
|
| Entity Voluntary Filers |
No
|
|
|
| Entity Current Reporting Status |
Yes
|
|
|
| Entity Interactive Data Current |
Yes
|
|
|
| Entity Filer Category |
Non-accelerated Filer
|
|
|
| Entity Small Business |
true
|
|
|
| Entity Emerging Growth Company |
false
|
|
|
| Entity Shell Company |
false
|
|
|
| Entity Public Float |
|
|
$ 161,163,094
|
| Entity Common Stock, Shares Outstanding |
|
146,949,320
|
|
| Auditor Name |
WithumSmith+Brown, PC
|
|
|
| Auditor Location |
San Francisco, California
|
|
|
| Auditor Firm ID |
100
|
|
|
| ICFR Auditor Attestation Flag |
false
|
|
|
| OUM & CO. LLP [Member] |
|
|
|
| Document Information [Line Items] |
|
|
|
| Auditor Name |
OUM & CO. LLP
|
|
|
| Auditor Location |
San Francisco, California
|
|
|
| Auditor Firm ID |
252
|
|
|